Chinese General Practice ›› 2022, Vol. 25 ›› Issue (12): 1533-1538.DOI: 10.12114/j.issn.1007-9572.2021.02.115
Special Issue: 神经系统疾病最新文章合集
• Research Methodology • Previous Articles
Received:
2021-09-28
Revised:
2021-11-05
Published:
2022-01-13
Online:
2022-03-21
Contact:
Yibing TAN
About author:
通讯作者:
谭益冰
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2021.02.115
条目 | CR | r值 | 条目 | CR | r值 |
---|---|---|---|---|---|
1 | 7.258a | 0.518a | 15 | 12.280a | 0.837a |
2 | 6.090a | 0.499a | 16 | 12.535a | 0.837a |
3 | 5.980a | 0.495a | 17 | 10.219a | 0.760a |
4 | 6.948a | 0.496a | 18 | 8.609a | 0.630a |
5 | 8.201a | 0.480a | 19 | 10.680a | 0.667a |
6 | 8.319a | 0.474a | 20 | 15.276a | 0.816a |
7 | 6.241a | 0.416a | 21 | 15.927a | 0.825a |
8 | 7.871a | 0.589a | 22 | 14.233a | 0.731a |
9 | 8.150a | 0.654a | 23 | 16.381a | 0.832a |
10 | 7.977a | 0.593a | 24 | 16.700a | 0.823a |
11 | 9.190a | 0.632a | 25 | 11.883a | 0.715a |
12 | 10.392a | 0.547a | 26 | 12.085a | 0.705a |
13 | 9.318a | 0.792a | 27 | 10.639a | 0.612a |
14 | 11.475a | 0.830a | 28 | 12.708a | 0.702a |
Table 1 Item analysis of the initial version of the High-risk People's Intention to Use Stroke Screening Scale
条目 | CR | r值 | 条目 | CR | r值 |
---|---|---|---|---|---|
1 | 7.258a | 0.518a | 15 | 12.280a | 0.837a |
2 | 6.090a | 0.499a | 16 | 12.535a | 0.837a |
3 | 5.980a | 0.495a | 17 | 10.219a | 0.760a |
4 | 6.948a | 0.496a | 18 | 8.609a | 0.630a |
5 | 8.201a | 0.480a | 19 | 10.680a | 0.667a |
6 | 8.319a | 0.474a | 20 | 15.276a | 0.816a |
7 | 6.241a | 0.416a | 21 | 15.927a | 0.825a |
8 | 7.871a | 0.589a | 22 | 14.233a | 0.731a |
9 | 8.150a | 0.654a | 23 | 16.381a | 0.832a |
10 | 7.977a | 0.593a | 24 | 16.700a | 0.823a |
11 | 9.190a | 0.632a | 25 | 11.883a | 0.715a |
12 | 10.392a | 0.547a | 26 | 12.085a | 0.705a |
13 | 9.318a | 0.792a | 27 | 10.639a | 0.612a |
14 | 11.475a | 0.830a | 28 | 12.708a | 0.702a |
Figure 1 Screen plot demonstrates the number and eigen values of items in exploratory factor analysis of the High-risk People's Intention to Use Stroke Screening Scale
序号 | 条目 | 积极态度 | 消极态度 | 主观规范 | 知觉行为控制 |
---|---|---|---|---|---|
1 | 中风高危筛查能尽早发现危险因素并干预,降低罹患中风的风险 | 0.548 | - | - | - |
2 | 中风高危筛查后及时采取措施,可以减少残疾和死亡 | 0.724 | - | - | - |
3 | 中风高危筛查后及时采取预防措施,可以减少将来的医疗费用 | 0.679 | - | - | - |
4 | 中风高危筛查后及时采取预防措施,可以减少患病对工作生活的影响 | 0.756 | - | - | - |
5 | 中风高危筛查能让我得到专业指导,获得预防中风的知识和(或)治疗 | 0.679 | - | - | - |
6 | 中风高危筛查能帮助我发现其他的健康问题 | 0.580 | - | - | - |
7 | 中风高危筛查会让我和家人更安心 | 0.690 | - | - | - |
8 | 我不愿意做中风高危筛查,因为怕"晦气" | - | 0.707 | - | - |
9 | 中风是命中注定的,中风高危筛查不能改变什么 | - | 0.759 | - | - |
10 | 中风高危筛查并不是确诊中风,筛查的结果是没有意义的 | - | 0.777 | - | - |
11 | 中风高危筛查的结果可能不好,自己接受不了 | - | 0.786 | - | - |
12 | 去社区做中风高危筛查,结果是不可信的 | - | 0.685 | - | - |
13 | 我愿意听取家人的建议去做中风高危筛查 | - | - | 0.772 | - |
14 | 我愿意听取朋友的建议去做中风高危筛查 | - | - | 0.818 | - |
15 | 我愿意听取同事等的建议去做中风高危筛查 | - | - | 0.825 | - |
16 | 我愿意听取社区的建议去做中风高危筛查 | - | - | 0.732 | - |
17 | 我愿意听取我信任的医护人员的建议,去做中风高危筛查 | - | - | 0.669 | - |
18 | 即使中风高危筛查的项目和流程复杂,我也会去做 | - | - | - | 0.789 |
19 | 即使中风高危筛查可能需要排队等待,我仍然会去做 | - | - | - | 0.788 |
20 | 即使中风高危筛查不是免费的,我也会自费去做 | - | - | - | 0.677 |
21 | 即使生活工作繁忙,我也会抽时间去做中风高危筛查 | - | - | - | 0.813 |
22 | 即使交通不便,我也会想办法去做中风高危筛查 | - | - | - | 0.828 |
23 | 即使中风高危筛查项目(如抽血)可能带来疼痛,我也愿意去做 | - | - | - | 0.734 |
24 | 即使中风高危筛查后可能还需要接受治疗,我也会去做 | - | - | - | 0.741 |
25 | 即使中风高危筛查的医护人员可能会批评我的生活方式,我也会去做 | - | - | - | 0.482 |
Table 2 Factor loadings of the final High-risk People's Intention to Use Stroke Screening Scale
序号 | 条目 | 积极态度 | 消极态度 | 主观规范 | 知觉行为控制 |
---|---|---|---|---|---|
1 | 中风高危筛查能尽早发现危险因素并干预,降低罹患中风的风险 | 0.548 | - | - | - |
2 | 中风高危筛查后及时采取措施,可以减少残疾和死亡 | 0.724 | - | - | - |
3 | 中风高危筛查后及时采取预防措施,可以减少将来的医疗费用 | 0.679 | - | - | - |
4 | 中风高危筛查后及时采取预防措施,可以减少患病对工作生活的影响 | 0.756 | - | - | - |
5 | 中风高危筛查能让我得到专业指导,获得预防中风的知识和(或)治疗 | 0.679 | - | - | - |
6 | 中风高危筛查能帮助我发现其他的健康问题 | 0.580 | - | - | - |
7 | 中风高危筛查会让我和家人更安心 | 0.690 | - | - | - |
8 | 我不愿意做中风高危筛查,因为怕"晦气" | - | 0.707 | - | - |
9 | 中风是命中注定的,中风高危筛查不能改变什么 | - | 0.759 | - | - |
10 | 中风高危筛查并不是确诊中风,筛查的结果是没有意义的 | - | 0.777 | - | - |
11 | 中风高危筛查的结果可能不好,自己接受不了 | - | 0.786 | - | - |
12 | 去社区做中风高危筛查,结果是不可信的 | - | 0.685 | - | - |
13 | 我愿意听取家人的建议去做中风高危筛查 | - | - | 0.772 | - |
14 | 我愿意听取朋友的建议去做中风高危筛查 | - | - | 0.818 | - |
15 | 我愿意听取同事等的建议去做中风高危筛查 | - | - | 0.825 | - |
16 | 我愿意听取社区的建议去做中风高危筛查 | - | - | 0.732 | - |
17 | 我愿意听取我信任的医护人员的建议,去做中风高危筛查 | - | - | 0.669 | - |
18 | 即使中风高危筛查的项目和流程复杂,我也会去做 | - | - | - | 0.789 |
19 | 即使中风高危筛查可能需要排队等待,我仍然会去做 | - | - | - | 0.788 |
20 | 即使中风高危筛查不是免费的,我也会自费去做 | - | - | - | 0.677 |
21 | 即使生活工作繁忙,我也会抽时间去做中风高危筛查 | - | - | - | 0.813 |
22 | 即使交通不便,我也会想办法去做中风高危筛查 | - | - | - | 0.828 |
23 | 即使中风高危筛查项目(如抽血)可能带来疼痛,我也愿意去做 | - | - | - | 0.734 |
24 | 即使中风高危筛查后可能还需要接受治疗,我也会去做 | - | - | - | 0.741 |
25 | 即使中风高危筛查的医护人员可能会批评我的生活方式,我也会去做 | - | - | - | 0.482 |
[1] |
《中国脑卒中防治报告》编写组. 《中国脑卒中防治报告2019》概要[J]. 中国脑血管病杂志,2020,17(5):272-281. DOI:10.3969/j.issn.1672-5921.2020.05.008.
|
[2] |
古贱秀,刘贞仔,蒋志民,等. 脑卒中危险因素筛查对脑卒中高危人群发病率及发病至入院时间的影响[J]. 中国当代医药,2021,28(16):76-78. DOI:10.3969/j.issn.1674-4721.2021.16.021.
|
[3] |
王陇德. 脑卒中筛查与防治工程:关注动脉硬化的高危因素——探求尽快降低我国脑卒中发病、死亡和伤残之策[J]. 中国医学前沿杂志:电子版,2011,3(3):1-3. DOI:10.3969/j.issn.1674-7372.2011.03.001.
|
[4] |
王陇德. 脑卒中筛查与干预:一项重大的国民保健工程[J]. 中国实用内科杂志,2010,30(11):965-967.
|
[5] |
刘芹,施燕红,牛晓兰,等. 社区脑卒中筛查的意义及规范化管理效果分析[J]. 中国初级卫生保健,2013,27(5):16-18. DOI:10.3969/j.issn.1001-568X.2013.05.0006.
|
[6] |
甘勇,杨婷婷,刘建新,等. 国内外脑卒中流行趋势及影响因素研究进展[J]. 中国预防医学杂志,2019,20(2):139-144. DOI:10.16506/j.1009-6639.2019.02.013.
|
[7] |
徐文杰,汤华山,闵晓玲,等. 社区居民脑卒中高危因素筛查干预工作流程探索[J]. 中国初级卫生保健,2020,34(11):42-44. DOI:10.3969/j.issn.1001-568X.2020.11.0011.
|
[8] |
中华人民共和国国家卫生健康委员会. 对十三届全国人大二次会议第1204号建议的答复[EB/OL]. (2019-07-22)[2021-09-20].
|
[9] |
宋斌,张桁忠,夏仲芳. 开展脑卒中高危人群筛查和干预项目的实践与思考[J]. 中国初级卫生保健,2015,29(10):26-27. DOI:10.3969/j.issn.1001-568X.2015.10.0011.
|
[10] |
|
[11] |
|
[12] |
刘琪. 胃癌风险人群筛查行为现况及基于计划行为理论胃癌筛查意向模型的构建[D]. 衡阳:南华大学,2020.
|
[13] |
程雪,许翠萍,张敏,等. 基于计划行为理论的无痛分娩意向自评量表构建[J]. 护理学报,2021,28(2):5-9. DOI:10.16460/j.issn1008-9969.2021.02.005.
|
[14] |
胡伟,胡秋月,韩文娟. 基于计划行为理论的重复献血行为调查量表的信效度分析[J]. 中国卫生统计,2020,37(1):24-27.
|
[15] |
吴晓丹,张美芬,郑美春,等. 结直肠癌健康信念量表的汉化及信效度研究[J]. 中国全科医学,2020,23(2):155-160. DOI:10.12114/j.issn.1007-9572.2019.00.335.
|
[16] |
|
[17] |
|
[18] |
梁霁,钱序,张雪,等. 宫颈癌筛查信念量表的信度和效度分析[J]. 中国妇幼保健,2013,28(36):5921-5925.
|
[19] |
张苗,刘晴,李沁梅,等. 中国妇女乳腺癌筛查保护动机量表的编制及信效度检验[J]. 中国健康教育,2021,37(4):303-307. DOI:10.16168/j.cnki.issn.1002-9982.2021.04.003.
|
[20] |
史静琤,莫显昆,孙振球. 量表编制中内容效度指数的应用[J]. 中南大学学报:医学版,2012,37(2):49-52. DOI:10.3969/j.issn.1672-7347.2012.02.007.
|
[21] |
吴明隆. SPSS统计应用实务:问卷分析与应用统计[M].北京:科学出版社,2003.
|
[22] |
梁娟,林征,许红,等. 二胎高龄妇女妊娠期需求量表的编制及信效度检验研究[J]. 中国全科医学,2018,21(17):2097-2100. DOI:10.3969/j.issn.1007-9572.2018.00.038.
|
[23] |
李峥,刘宇. 护理学研究方法[M]. 2版. 北京:人民卫生出版社,2018.
|
[24] |
|
[25] |
秦浩,陈景武. 医学量表条目的筛选考评方法及其应用[J]. 中国行为医学科学,2006(4):375-376. DOI:10.3760/cma.j.issn.1674-6554.2006.04.039.
|
[26] |
张学权,王丹丹. 脑卒中高危人群对定期筛查调查的意愿及影响因素分析[J]. 中国乡村医药,2020,27(8):18-19. DOI:10.19542/j.cnki.1006-5180.003892.
|
[27] |
陈璐,闵艳. 南京市秦淮区脑卒中高危人群脑卒中认知情况及定期筛查意愿现状研究[J]. 实用预防医学,2020,27(12):1511-1514. DOI:10.3969/j.issn.1006-3110.2020.12.028.
|
[28] |
张文彤,董伟. SPSS统计分析高级教程[M]. 2版. 北京:高等教育出版社,2013.
|
[29] |
[1] | QIN Fengyin, ZHANG Qishan, LAI Jinjia, HUANG Yimin, HAN Guoyin, SUN Xinglan, WANG Fen, TAN Yibing. Current Status and Influencing Factors of the Intention to Screen for High-risk Stroke among Community Residents in Guangdong [J]. Chinese General Practice, 2023, 26(34): 4283-4289. |
[2] | SU Kaiqi, LYU Zhuan, WU Mingli, LUO Meng, GAO Jing, NIE Chenchen, LIU Hao, FENG Xiaodong. Effect of Electroacupuncture on BDNF/TrkB/PI3K/Akt Pathway and Hippocampal Neuronal Protection in Rats with Learning and Memory Impairment after Ischemia Reperfusion [J]. Chinese General Practice, 2023, 26(33): 4187-4193. |
[3] | YIN Miaomiao, CUI Liling, LI Yaqing, WANG Liqun, ZHANG Yue, WU Jialing. Effect of Dual Task on Walking Ability in Posterior Circulation Ischemic Stroke Patients with Vestibular Symptoms [J]. Chinese General Practice, 2023, 26(33): 4207-4212. |
[4] | JIAN Qiufeng, XU Ronghua, YAO Qian, ZHOU Yuanyuan. A Meta-analysis of the Prevalence and Influencing Factors of Post-stroke Cognitive Impairment in Chinese Elderly Patients [J]. Chinese General Practice, 2023, 26(32): 4070-4079. |
[5] | YANG Yuxuan, ZHANG Han, DU Juan, WANG Lingling, XIE Yulei, YIN Kaiming, ZHANG Bo. Value of an Dynamic Eye-tracking Task in Assessing Unilateral Spatial Neglect after Stroke [J]. Chinese General Practice, 2023, 26(32): 4020-4025. |
[6] | ZHU Lin, GUO Yankui, GAO Chen, CHEN Xuezhi, WANG Fashuai. Efficacy of Western Medicine, Chinese Patent Medicine and Their Combination on Post-stroke Insomnia: a Network Meta-analysis [J]. Chinese General Practice, 2023, 26(30): 3823-3832. |
[7] | XIAO Yuqian, BAI Yanjie, WANG Yan, CHEN Shuying, CHEN Limin, SUN Kexin, WAN Jun. Research Progress of Mitochondrial Transfer in Post-stroke Cognitive Impairment [J]. Chinese General Practice, 2023, 26(30): 3833-3840. |
[8] | LIU Yue, LIU Qi, DONG Hui, LIU Yaling. Neuropsychological Changes of Cognitive Reverters after Stroke Based on the Montreal Cognitive Assessment (MoCA) with a Double Threshold [J]. Chinese General Practice, 2023, 26(27): 3417-3422. |
[9] | ZHENG Siting, HE Chunyu, ZHOU Jun, KONG Ye, YANG Xinyao, ZHOU Haiying, WEI Xiaofei. Summary of Best Evidence for Self-Management of Patients with Motor Dysfunction after Stroke [J]. Chinese General Practice, 2023, 26(26): 3230-3237. |
[10] | Expert group of expert consensus on the application of ulinastatin in common clinical critical illness. Expert Consensus on the Application of Ulinastatin in Common Clinical Critical Illness [J]. Chinese General Practice, 2023, 26(26): 3207-3219. |
[11] | WANG Xiaowen, XIAO Tongling, WANG Yi, YANG Ying, XIA Xiaoshuang, LI Xin. Relationship between Homocysteine Level and Acute Kidney Injury in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2023, 26(26): 3290-3296. |
[12] | DU Yuying, WANG Cailing, CUI Senlin, LEI lei, WANG Yanping, SONG Xueqin, HAN Shuqin, ZHANG Yanmei, WANG Baolan, HUANG Haixia, CHEN Mi, YAN Huirong, LI Dong, ZHANG Jingjing, REN Yu. Analysis of Appropriate Technology Promotion for Stroke Rehabilitation in Southern Xinjiang [J]. Chinese General Practice, 2023, 26(25): 3178-3184. |
[13] | ZHANG Guoqing, TONG Tingting, WANG Ying, LI Kuiwu, ZHANG Lida, WU Xiaoqing, LI Chenglong, WANG Junli, ZHANG Junyu, HAN Wei. Effect and Mechanism of Tongdu Tiaoshen Electroacupuncture Pretreatment-mediated MiR-124-3p/GSK-3β/Cyp-D Signaling Pathway on Mitochondrial Permeability Transition Pore in Cerebral Cortex of Rats with Cerebral Ischemia-reperfusion Injury [J]. Chinese General Practice, 2023, 26(24): 3050-3060. |
[14] | ZHANG Xingshan, LIN Yue, WAN Chonghua, SONG Aifeng, PAN Haiyan. A Nephrotic Syndrome-specific Quality of Life Scale: Development Based on the Quality of Life Instruments for Chronic Diseases, and Verification Using the Classical Test Theory [J]. Chinese General Practice, 2023, 26(20): 2488-2495. |
[15] | WU Xiaoyu, WAN Chonghua, CHEN Ying, RUAN Yanqin, WENG Yijie, XU Xiaojiang. A Review of Studies on Patient-reported Outcomes and Disease-specific Health-related Quality of Life Instruments for Irritable Bowel Syndrome [J]. Chinese General Practice, 2023, 26(18): 2268-2276. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||